What are Medifast's total assets?

Medifast (MED) holds $252.0M in total assets, down 10.0% year over year.

How much debt does Medifast have?

Medifast carries $16.1M in total debt against $197.7M of shareholders' equity, a debt-to-equity ratio of 0.08.

How much cash does Medifast have?

Medifast holds $71.5M in cash and equivalents.

Can Medifast cover its short-term obligations?

Its current ratio is 4.80 — current assets exceed current liabilities.

Where does Medifast's balance sheet data come from?

Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Medifast MED Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$71.53M-22.0%	$89.3M-1.8%	$99.53M-13.7%	$101.69M-5.9%	$91.72M-5.9%
Short-term investments	$97.42M+33.7%	$77.97M+9.2%	$73.99M+35.4%	$60.98M+9.9%	$72.88M+23.6%
Inventories	$21.4M-45.6%	$20.23M-52.3%	$23.21M-42.1%	$30.2M-23.7%	$39.36M-14.9%
Raw materials	$6.47M-11.2%	$4.92M-26.7%	$6.5M+6.3%	$7.7M+39.8%	$7.29M+14.9%
Finished goods	$16.49M-45.6%	$16.79M-50.2%	$18.04M-42.4%	$22.2M-30.0%	$30.29M-17.6%
Prepaid expenses and other current assets	$6.97M-27.2%	$9.07M-5.9%	$6.82M+1.9%	$9.05M-27.4%	$9.57M-16.2%
Income taxes receivable	$5.32M—	$5.12M—	$4.3M-47.7%	$4.51M-48.3%	——
Assets held for sale	——	$1.4M—	——	——	——
Total current assets	$202.63M-5.1%	$201.68M-5.9%	$207.84M-7.6%	$206.44M-8.0%	$213.52M-2.8%
Property and equipment, net	$29.64M-18.4%	$31.23M-16.8%	$32.85M-15.8%	$34.6M-13.3%	$36.31M-28.8%
Operating lease right-of-use assets	3.5%+1.3%	723,200,000%-392,300,000%	2.3%0.0%	2.2%-0.1%	2.2%-0.1%
Deferred tax assets	$0-100%	$0-100%	$12.11M+203%	$11.46M+179%	$11.44M+186%
Other non-current assets	$6.85M-21.5%	$7.83M-19.0%	$7.02M-36.0%	$7.98M-32.2%	$8.73M-36.1%
Total assets	$252.05M-10.0%	$247.97M-12.8%	$268.21M-7.9%	$269.33M-8.2%	$280.01M-7.5%
Accounts payable	$38.26M-26.2%	$38.36M-32.1%	$41.24M-37.8%	$40.26M-41.8%	$51.82M-27.3%
Operating lease liabilities, current	$3.92M-36.3%	$4.6M-25.5%	$5.47M-10.4%	$5.92M-1.8%	$6.16M+3.3%
Dividends payable	$206K-54.5%	——	$441K-32.7%	$452K-31.4%	$453K-35.0%
Total current liabilities	$42.18M-30.4%	$42.96M-33.0%	$46.71M-35.5%	$46.18M-38.6%	$60.6M-21.5%
Operating lease liabilities, non-current	$12.18M+44.1%	$6.09M-38.7%	$6.79M-41.1%	$7.14M-45.3%	$8.45M-42.1%
Operating Lease Liabilities (Total)	$16.1M+10.2%	$10.69M-33.7%	$12.26M-30.4%	$13.07M-31.6%	$14.61M-29.0%
Total liabilities	$54.37M-21.3%	$49.05M-33.8%	$53.5M-36.2%	$53.33M-39.6%	$69.05M-24.8%
Common stock	20M0.0%	20M+181,718%	20M0.0%	20M0.0%	20M0.0%
Additional paid-in capital	$41.49M+19.6%	$40.41M+21.9%	$38.23M+23.3%	$37.32M+22.8%	$34.7M+24.1%
Retained earnings	$156.15M-11.3%	$158.27M-10.5%	$176.24M+0.2%	$178.49M+2.1%	$176.01M-3.8%
Accumulated other comprehensive income (loss)	$33K-86.2%	$234K+30.0%	$220K-37.0%	$179K+588%	$239K+986%
Total stockholders' equity	$197.68M-6.3%	$198.92M-5.3%	$214.71M+3.6%	$216.01M+5.2%	$210.96M0.0%
Total liabilities and stockholders' equity	$252.05M-10.0%	$247.97M-12.8%	$268.21M-7.9%	$269.33M-8.2%	$280.01M-7.5%
Cash Cash Equivalents And Short Term Investments	$168.44M+0.8%	$166.35M+0.4%	$172.81M+0.1%	$161.91M-1.7%	$167.14M+9.0%
Other Inventory, Net	$3.74M+220%	$4.34M+200%	$3.99M+191%	$2.31M+79.4%	$1.17M-15.8%
Deferred Tax Assets and Other Non-Current Assets	$6.85M-21.5%	$7.83M-19.0%	$7.02M-36.0%	$7.98M-32.2%	$8.73M-36.1%
Net Investment in Lease	$12.92M+29.1%	$7.23M-35.2%	$8.4M-31.7%	$8.86M-34.0%	$10.01M-31.1%
Operating lease right-of-use assets	$12.92M+29.1%	$7.23M-35.2%	$8.4M-31.7%	$8.86M-34.0%	$10.01M-31.1%
Other non-current assets	$6.85M-21.5%	$7.83M-19.0%	$7.02M-36.0%	$7.98M-32.2%	$8.73M-36.1%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$97.42M+33.7%	$77.97M+9.2%	$73.99M+35.4%	$60.98M+9.9%	$72.88M+23.6%
Operating Lease Right-of-Use Assets in Other Assets	$12.92M+29.1%	$7.23M-35.2%	$8.4M-31.7%	$8.86M-34.0%	$10.01M-31.1%
Software and Technology Licenses, Net	$6.85M-21.5%	$7.83M-19.0%	$7.02M-36.0%	$7.98M-32.2%	$8.73M-36.1%
Accounts payable and other current liabilities (Note 11)	$38.26M-26.2%	$38.36M-32.1%	$41.24M-37.8%	$40.26M-41.8%	$51.82M-27.3%
Lease Liability Payments - 2020 (Remaining Three Months)	$3.51M-27.7%	——	$1.63M+2.3%	$3.25M+2.4%	$4.86M+2.4%
Operating Lease Liability Payments - 2024 (Lessee)	$3.91M+53.2%	——	$2.79M-41.7%	$2.55M-46.6%	$2.55M-46.6%
Operating Lease Liability Payments - 2025 (Lessee)	$1.12M+365%	——	$525K-79.9%	$240K-90.8%	$240K-90.8%
Lease Liability Payments - Due Year Two	$3.91M+53.2%	——	$2.79M-41.7%	$2.55M-46.6%	$2.55M-46.6%
Lease Liability Payments - Due Year Three	$1.57M-40.2%	——	$2.9M+13.4%	$2.62M+2.5%	$2.62M+2.5%
Lease Liability Payments - Due Year Four	$1.12M+365%	——	$525K-79.9%	$240K-90.8%	$240K-90.8%
Lease Liability Payments - Remainder of Fiscal Year	$3.78M-21.0%	——	$4.78M-26.0%	$4.78M-26.0%	$4.78M-26.0%
Operating Lease Liability Payments Due	$18.13M+20.4%	——	$12.67M-30.6%	$13.44M-32.2%	$15.06M-29.7%
Operating Lease Liability - Undiscounted Excess Amount	$2.03M+354%	——	$410K-34.3%	$372K-48.8%	$446K-46.7%
Operating Lease Liability Payments - 2027 (Lessee)	$1.57M-40.2%	——	$2.9M+13.4%	$2.62M+2.5%	$2.62M+2.5%
Operating Lease Liability Payments - 2028 (Lessee)	$1.12M+365%	——	$525K-79.9%	$240K-90.8%	$240K-90.8%
Total debt	$16.1M+10.2%	$10.69M-33.7%	$12.26M-30.4%	$13.07M-31.6%	$14.61M-29.0%
AOCI - Available-for-Sale Securities, Net of Tax	$31K-87.0%	$231K+27.6%	——	——	$239K+335%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	11.1M+1.2%	11M+0.5%	11M+0.5%	11M+0.5%	11M+0.5%
Common Stock Shares Outstanding	$0—	——	$0—	$0—	$0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$11K0.0%	$11K0.0%	$11K0.0%	$11K0.0%	$11K0.0%
Number of Exercisable Options	22K0.0%	——	22K0.0%	22K-4.3%	22K0.0%
Share-Based Payment Award Options Outstanding - Number	22K0.0%	22K0.0%	22K0.0%	22K-4.3%	22K0.0%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$0—	——	$0—	$0—	$0—
Weighted Average Exercise Price of Outstanding Options	$66.680.0%	$66.680.0%	$66.680.0%	$66.680.0%	$66.680.0%
Cash, Cash Equivalents, And Short-Term Investments, Fair Value Disclosure	$168.95M+2.6%	$167.27M+3.0%	$173.51M+2.1%	$162.67M-0.5%	$164.59M+5.2%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%
Common stock, shares issued (in shares)	$11.12M+1.2%	$10.99M+0.5%	$10.99M+0.5%	$10.99M+0.5%	$10.99M+0.5%
Common Stock, Shares, Outstanding	$11.12M+1.2%	$10.99M+0.5%	$10.99M+0.5%	$10.99M+0.5%	$10.99M+0.5%
Accrued Interest, Debt securities	$465K-1.9%	$613K+45.3%	$406K-5.1%	$527K+51.9%	$474K—
Cost not yet recognized	$0—	——	——	——	$0—
Inventory Non Food Finished Goods	$1.03M-37.2%	$1.22M-40.1%	$1.29M-41.5%	$1.46M-40.3%	$1.63M-43.2%
Raw materials	$6.47M-11.2%	$4.92M-26.7%	$6.5M+6.3%	$7.7M+39.8%	$7.29M+14.9%
Lessee Operating Lease Liability Payments Due	$18.13M+20.4%	——	$12.67M-30.6%	$13.44M-32.2%	$15.06M-29.7%
Thereafter	$4.25M—	——	$49K-79.6%	——	$0-100%
Lessee Operating Lease Liability Undiscounted Excess Amount	$2.03M+354%	——	$410K-34.3%	$372K-48.8%	$446K-46.7%
Operating Lease Weighted Average Discount Rate Percent	$0.04+59.1%	——	$0.020.0%	$0.02-4.3%	$0.02-4.3%
Packaging and other supplies	$1.16M-12.7%	$1.65M+15.7%	$1.37M-24.8%	$1.15M-5.7%	$1.33M-20.6%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$22K0.0%	——	$22K0.0%	$22K-4.3%	$22K0.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$22K0.0%	$22K0.0%	$22K0.0%	$22K-4.3%	$22K0.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$66.680.0%	$66.680.0%	$66.680.0%	$66.680.0%	$66.680.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$0—	——	$0—	$0—	$0—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$66.680.0%	——	$66.680.0%	$66.680.0%	$66.680.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$0—	——	$0—	$0—	$0—
Short-Term Investments, Unrealized Gain (Loss)	$41K+101%	$309K+108%	$294K+109%	$241K+115%	-$3.02M—
Remainder of Fiscal Year 2024	$3.51M-27.7%	——	$1.63M+2.3%	$3.25M+2.4%	$4.86M+2.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Medifast.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Medifast's total assets?: Medifast (MED) holds $252.0M in total assets, down 10.0% year over year.
How much debt does Medifast have?: Medifast carries $16.1M in total debt against $197.7M of shareholders' equity, a debt-to-equity ratio of 0.08.
How much cash does Medifast have?: Medifast holds $71.5M in cash and equivalents.
Can Medifast cover its short-term obligations?: Its current ratio is 4.80 — current assets exceed current liabilities.
Where does Medifast's balance sheet data come from?: Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.